Research Article
Butyrylcholinesterase Levels on Admission Predict Severity and 12-Month Mortality in Hospitalized AIDS Patients
Table 1
Patient basic characteristics (
).
| | Parameter | Value |
| | Age (years) (mean ± SD) | 41.8 ± 13.8 | | Sex [n(%)] | | | Male | 441 (87.3%) | | Female | 64 (12.7%) | | CD4+ (cells/μL) [median (IRQ)] | 76 (20–233) | | WHO disease stage [n (%)] | | | I/II | 97 (19.2) | | III | 119 (23.6) | | Pulmonary tuberculosis | 23 (4.6) | | Bacterial pneumonia | 18 (3.6) | | Other diseases | — | | IV | 289 (57.2) | | Pneumocystis pneumonia | 106 (21.0) | | Extrapulmonary tuberculosis | 78 (15.4) | | Cryptococcal meningitis | 42 (8.3) | | Severe bacterial pneumonia | 38 (7.5) | | Fungal infection in bloodstream | 13 (2.6) | | Recurrent septicaemia | 10 (2.0) | | Nontuberculosis mycobacteria | 5 (1.0) | | Lymphoma | 17 (3.4) | | Other diseases | — | | HIV-RNA (log10 copies/mL) | 4.3 ± 1.4 | | Serum BChE (U/L) | 6073.8 ± 2280.8 | | Serum albumin (g/L) | 35.6 ± 7.5 | | Body mass index | 20.4 ± 3.1 | | Hemoglobin (g/L) | 116.8 ± 26.5 | | Serum sodium (mmol/L) | 137.8 ± 4.6 |
|
|
BChE: butyrylcholinesterase; IQR: interquartile range; WHO: World Health Organization; HIV-RNA was available in 54 patients. |
